Diquafosol ophthalmic solution 3 % | 合法藥品大搜索

1) A single dose administration of diquafosol sodium into the eyes of normal animals (rabbits and rats) promoted tear fluid secretion and mucin secretion from the ... Read More

由 JH Park 著作 · 2018 · 被引用 13 次 — It has been demonstrated that diquafosol is a dinucleotide derivative of UTP, and nucleotides including ATP and UTP control the process of tearing, wound healing​ ... Read More

由 S Amano 著作 · 2017 · 被引用 14 次 — In conclusion, diquafosol sodium ophthalmic solution improves MGD and dry eye​-related signs and symptoms in subjects with MGD. Also, the use ... Read More

Diquafosol (tradename Diquas) is a pharmaceutical drug for the treatment of dry eye disease. It was approved for use in Japan in 2010. It is formulated as a 3% ... Read More

治療乾性角結膜炎病人之角膜以及結膜上皮損傷. 用法用量. 詳見仿單. 藥品說明書. 主要成分. Diquafosol Sodium. 詳細資料. 英文品名, Diquas Ophthalmic solution. Read More

由 JH Park 著作 · 2018 · 被引用 13 次 — Diquafosol Sodium Inhibits Apoptosis and Inflammation of Corneal Epithelial Cells Via Activation of Erk1/2 and RSK: In Vitro and In Vivo Dry Eye ... Read More

由 GM Keating 著作 · 2015 · 被引用 54 次 — Diquafosol ophthalmic solution 3 % (Diquas(®)) is a P2Y2 receptor agonist that promotes tear fluid and mucin secretion and is currently approved in Japan and ... Read More

由 C Shigeyasu 著作 · 2015 · 被引用 16 次 — Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition. Jpn J Ophthalmol. Read More

由 K Nam 著作 · 2019 · 被引用 5 次 — However, treatment with sodium hyaluronate alone was inadequate for the improvement of subjective or objective symptoms in some dry eye ... Read More